Annovis Bio, Inc. (ANVS) › Operating Cash FlowAnnovis Bio, Inc. (ANVS) — Operating Cash FlowAnnual figures by period end, from SEC filings.2019-12-31: -$476.5K2020-12-31: -$3.97M2021-12-31: -$9.13M2022-12-31: -$17.31M2023-12-31: -$39.97M2024-12-31: -$21.89M2025-12-31: -$25.62M-$25.62M2019-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$25.62M—2026-03-13From 2025-01-012024-12-31-$21.89M—2026-03-13From 2024-01-012023-12-31-$39.97M—2025-03-21From 2023-01-012022-12-31-$17.31M—2024-03-29From 2022-01-012021-12-31-$9.13M—2023-03-31From 2021-01-012020-12-31-$3.97M—2022-03-02From 2020-01-012019-12-31-$476.5K—2021-03-03From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)